Concord Biotech appoints Raviraj Karia as CFO in place of Lalit Sethi
This story was originally published at 14:12 IST on 18 December 2025
Register to read our real-time news.Informist, Thursday, Dec. 18, 2025
--Concord Biotech board OKs appointing Raviraj Karia as CFO effective Thu
NEW DELHI – Concord Biotech Ltd.'s board has approved the appointment of Raviraj Karia as the company's chief financial officer, effective Thursday. On Tuesday, Informist had exclusively reported that Karia is set to take over as the company's chief financial officer from Jan. 5, as Lalit Sethi had expressed his desire to retire early from the position for personal reasons.
Karia is a chartered accountant and has an experience of over 23 years across pharmaceuticals, healthcare, clinical research, logistics, and private equity, Concord Biotech said in an exchange filing. He has previously worked with Intas Pharmaceuticals, Sakar Healthcare Ltd., Lambda Therapeutics, Shalby Hospitals, Gati, GVFL, and Claris Lifesciences.
For the September quarter, Concord Biotech had reported a consolidated net profit of INR 635.81 million on a revenue of INR 2.47 billion. At 1409 IST, shares of the company were up 0.5% at INR 1,338.40 on the National Stock Exchange. End
IST, or Indian Standard Time, is five-and-a-half hours ahead of GMT
Reported by Anand JC
Edited by Nishant Maher
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2025. All rights reserved.
To read more please subscribe
Share this Story:
